
Dermabio offers an AI-powered precision medicine platform that helps clinicians choose effective biologic therapies faster and with fewer trials. It combines skin biomarker analysis, a proprietary clinical assay, and advanced data modeling to predict patient response. The non-invasive skin swab integrates into clinical workflows, delivering actionable data for clinicians and payers. The platform operates as a B2B SaaS solution for healthcare providers and payers, enabling scalable, data-driven decision making.

Dermabio offers an AI-powered precision medicine platform that helps clinicians choose effective biologic therapies faster and with fewer trials. It combines skin biomarker analysis, a proprietary clinical assay, and advanced data modeling to predict patient response. The non-invasive skin swab integrates into clinical workflows, delivering actionable data for clinicians and payers. The platform operates as a B2B SaaS solution for healthcare providers and payers, enabling scalable, data-driven decision making.